Table 2.
MR results of causal links between the gut microbiome and COVID-19 risk p<5×10−8.
| Nsnp | Method | Beta | SE | P value | OR (95% CI) | Horizontal pleiotropy | Heterogeneity | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Egger intercept | SE | P value | Cochran’s Q | P value | |||||||
| COVID-19 susceptibility | 12 | MR–Egger | −0.060 | 0.127 | 0.644 | 0.941 (0.734–1.207) | 0.011 | 0.014 | 0.424 | 81.605 | 7.21E−13 |
| Weighted median | 0.034 | 0.020 | 0.089 | 1.035 (0.995–1.077) | |||||||
| Inverse variance weighted | 0.041 | 0.036 | 0.259 | 1.042 (0.970–1.118) | |||||||
| Weighted mode | 0.043 | 0.026 | 0.126 | 1.043 (0.992–1.097) | |||||||
| COVID-19 severity | 12 | MR–Egger | −0.227 | 0.326 | 0.503 | 0.797 (0.420–1.511) | 0.033 | 0.035 | 0.366 | 55.472 | 6.35E−08 |
| Weighted median | 0.029 | 0.059 | 0.624 | 1.030 (0.916–1.157) | |||||||
| Inverse variance weighted | 0.069 | 0.095 | 0.469 | 1.071 (0.889–1.291) | |||||||
| Weighted mode | 0.016 | 0.073 | 0.827 | 1.016 (0.881–1.173) | |||||||
| COVID-19 hospitalization | 12 | MR–Egger | −0.109 | 0.221 | 0.633 | 0.897 (0.581–1.384) | 0.019 | 0.024 | 0.431 | 56.604 | 3.94E−08 |
| Weighted median | 0.005 | 0.040 | 0.897 | 1.005 (0.929–1.088) | |||||||
| Inverse variance weighted | 0.065 | 0.063 | 0.304 | 1.067 (0.943–1.207) | |||||||
| Weighted mode | 0.004 | 0.044 | 0.931 | 1.004 (0.921–1.094) | |||||||